SK

Sudheesh Kumar Sukumaran Radhamony

Active Director Director DIN 06953154
DIN 06953154 First appointment Oct 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sudheesh Kumar Sukumaran Radhamony

Data last updated:

Sudheesh Kumar Sukumaran Radhamony is a Director at Medcare Guardian Private Limited (since 2025).

DIN 06953154
Primary Designation Director
First Appointment 01 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medcare Guardian Private Limited U62099KL2025PTC097591
Director01 Oct 20252025Active

Board colleagues of Sudheesh Kumar Sukumaran Radhamony

Directorship timeline

Open interactive timeline →
Medcare Guardian Private Limited
Premium access

Shareholding and investment profile for Sudheesh Kumar Sukumaran Radhamony

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudheesh Kumar Sukumaran Radhamony

Sudheesh Kumar Sukumaran Radhamony currently holds 1 directorship: Medcare Guardian Private Limited (Director, since 01 Oct 2025).

Sudheesh Kumar Sukumaran Radhamony was first appointed on 01 Oct 2025 as Director at Medcare Guardian Private Limited.

The current boards of Sudheesh Kumar Sukumaran Radhamony's companies include Ganesh (Medcare Guardian Private Limited), Lijo Jose Jamuna Wilfred Jose (Medcare Guardian Private Limited), Vivek Chandran Suja (Medcare Guardian Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available